Pegaptanib 1-Year Systemic Safety Results from a Safety–Pharmacokinetic Trial in Patients with Neovascular Age-Related Macular Degeneration
- 16 May 2007
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 114 (9), 1702-1712.e2
- https://doi.org/10.1016/j.ophtha.2007.02.021
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathyBritish Journal of Ophthalmology, 2004
- Causes and Prevalence of Visual Impairment Among Adults in the UnitedStatesArchives of Ophthalmology (1950), 2004
- VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal NeovascularizationThe Journal of Experimental Medicine, 2003
- Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primateAmerican Journal of Ophthalmology, 2002
- Prevention of Experimental Choroidal Neovascularization With Intravitreal Anti–Vascular Endothelial Growth Factor Antibody FragmentArchives of Ophthalmology (1950), 2002
- Vascular Endothelial Growth Factor Is Sufficient to Produce Iris Neovascularization and Neovascular Glaucoma in a Nonhuman PrimateArchives of Ophthalmology (1950), 1996
- Inhibition of Vascular Endothelial Growth Factor Prevents Retinal Ischemia—Associated Iris Neovascularization in a Nonhuman PrimateArchives of Ophthalmology (1950), 1996
- Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.Proceedings of the National Academy of Sciences, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Age-related Macular Degeneration Histopathologic StudiesOphthalmology, 1993